Abstract
Aliskiren (Tekturna), a direct renin inhibitor, was FDA-approved in 2007 for treatment of hypertension. Researchers conducted this industry-sponsored
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have